Idarucizumab: What Should We Know?
Cortese F, Calculli G, Gesualdo M, Cecere A, Zito A, De Vito F, Carbonara R, Carbonara S, Cortese AM, Ciccone MM.
Cortese F, et al.
Curr Drug Targets. 2018;19(1):81-88. doi: 10.2174/1389450118666170925155943.
Curr Drug Targets. 2018.
PMID: 28950812
Review.